Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OrganiGram Holdings Inc OGI


Primary Symbol: T.OGI

Healthcare Cannabis
Organigram Holdings Inc. operates through its subsidiaries. The Company’s major wholly owned subsidiaries include Organigram Inc., 10870277 Canada Inc., The Edibles and Infusions Corporation (EIC), and Laurentian Organic Inc. (Laurentian). Organigram Inc. is a licensed producer (LP) of cannabis, cannabis-derived products and cannabis infused edibles in Canada. It is focused on producing... see more

Recent & Breaking News (TSX:OGI)

Organigram Reports Third Quarter Fiscal 2022 Results

Business Wire July 14, 2022

Organigram to Report Third Quarter 2022 Results on July 14, 2022

Business Wire July 8, 2022

Proposed Settlement Reached in 2016 Class Action

Business Wire June 23, 2022

Organigram Reports Second Quarter Fiscal 2022 Results

Business Wire April 12, 2022

The StockTalk Cannabis Report: April 8, 2022

Dave Jackson April 8, 2022

Organigram to report Q2 2022 results on April 12

Stockhouse Editorial April 4, 2022

Organigram to Report Second Quarter 2022 Results on April 12, 2022

Business Wire April 1, 2022

Organigram Provides Corporate Update and Announces New Product Launches

Business Wire March 24, 2022

Organigram Joins the Pledge 1% Movement

Business Wire March 17, 2022

BAT Exercises Top-Up Rights to Invest $6.3 Million Resulting in an Increase in Equity Position from 18.8% to 19.5%

Business Wire February 28, 2022

Organigram Holdings Inc. Announces Election of Directors

Business Wire February 23, 2022

Organigram Reports First Quarter Fiscal 2022 Results

Business Wire January 11, 2022

Organigram to Report First Quarter Fiscal 2022 Results on January 11, 2022

Business Wire January 5, 2022

Organigram Makes Additional $2.5 Million Investment in Hyasynth Biologicals, a Leading Cannabinoid Biosynthesis Company

Business Wire December 22, 2021

Organigram Acquires Quebec-Based Laurentian Organic Inc. in Accretive Transaction

Business Wire December 21, 2021

S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index

PR Newswire December 3, 2021

Organigram Reports Fourth Quarter Fiscal 2021 Results

Business Wire November 23, 2021

Organigram Launches New Wellness Brand, Monjour

Business Wire November 18, 2021

Organigram to Report Fourth Quarter and Full Year Fiscal 2021 Results on November 23, 2021

Business Wire November 15, 2021

Organigram Provides Corporate Update

Business Wire November 1, 2021